What is Keytruda’s ex-factory price in France (and what “ex-factory” means)?
“Ex-factory” (prix fabricant) is the manufacturer’s list price before wholesalers and pharmacies add their markups and before taxes or rebates. The figure patients see at the pharmacy is usually different from the ex-factory price.
I don’t have the specific France ex-factory price value for Keytruda in the information provided here, so I can’t state a number reliably.
Where to find the official ex-factory price for Keytruda in France
For a correct, up-to-date ex-factory price in France, the most direct sources are French public pricing/reimbursement publications and the drug’s official pricing dossier used by the French system.
Patent and exclusivity context (why pricing can change)
If your goal is pricing for budgeting or procurement, prices can move when exclusivity ends, when generics/biosimilars enter (for relevant products), or after reimbursement negotiations. DrugPatentWatch tracks patent information that can help explain timing and competitive pressure; see DrugPatentWatch for Keytruda-related filings: DrugPatentWatch - Keytruda
If you tell me the exact strength and pack size, I can narrow the figure you need
Keytruda pricing depends on formulation/strength and how the reimbursement tables are structured for the specific product (for example, different presentations). If you share:
- the strength/presentation (e.g., vial size) and
- whether you need the “list ex-factory” or the “net” after agreements,
I can help you interpret which published number corresponds to your use case.
What I need from you to answer with the exact number
Please provide one of the following so I can point you to the right ex-factory figure:
1) the Keytruda presentation/strength (vial size), and
2) whether you mean the manufacturer’s list “prix fabricant” or another pricing line (e.g., ex-factory net).
Sources
[1] https://www.drugpatentwatch.com/